Umbralisib in Combination with Ibrutinib in Patients with Relapsed or Refractory Chronic Lymphocytic Leukaemia or Mantle Cell Lymphoma: A Multicentre Phase 1–1b Study

Drug Category : Array
Conference Category : Array
Lead Author : Davids M, et al.
Published Date : 14/12/2018
Download Link : https://www.thelancet.com/journals/lanhae/article/PIIS2352-3026(18)30196-0/fulltext
Download Text : Download
Popup Confirmation? :
site-sidebar-layout : default
ast-site-content-layout : default
site-content-style : default
site-sidebar-style : default
theme-transparent-header-meta : default
stick-header-meta : default
astra-migrate-meta-layouts : set
Scroll to Top